Restricted substrate specificity for the geranylgeranyltransferase-i enzyme in cryptococcus neoformans: Implications for virulence

Eukaryotic Cell

Volumn 12, Issue 11, 2013, Pages 1462-1471

  Selvig, Kyla ^a   Ballou, Elizabeth R ^a   Nichols, Connie B ^a   Alspaugh, J Andrew ^a  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CYCLE PROTEIN; DIMETHYLALLYLTRANSFERASE; FUNGAL PROTEIN; GERANYLGERANYLTRANSFERASE TYPE I; GERANYLGERANYLTRANSFERASE TYPE-I; TRANSFERASE;

ARTICLE; CRYPTOCOCCUS NEOFORMANS; ENZYME SPECIFICITY; ENZYMOLOGY; GENETICS; METABOLISM; PATHOGENICITY; PROTEIN PRENYLATION; VIRULENCE;

ALKYL AND ARYL TRANSFERASES; CELL CYCLE PROTEINS; CRYPTOCOCCUS NEOFORMANS; DIMETHYLALLYLTRANSTRANSFERASE; FUNGAL PROTEINS; PROTEIN PRENYLATION; SUBSTRATE SPECIFICITY; VIRULENCE;

EID: 84886390606     PISSN: 15359778     EISSN: None     Source Type: Journal    
DOI: 10.1128/EC.00193-13     Document Type: Article

References (54)

1. Nguyen UT, Goody RS, Alexandrov K. 2010. Understanding and exploiting protein prenyltransferases. Chembiochem 11:1194-1201.
2. Basso AD, Kirschmeier P, Bishop WR. 2006. Lipid posttranslational modifications. Farnesyl transferase inhibitors. J. Lipid Res. 47:15-31.
3. Casey PJ, Seabra MC. 1996. Protein prenyltransferases. J. Biol. Chem. 271:5289-5292.
4. Reid TS, Terry KL, Casey PJ, Beese LS. 2004. Crystallographic analysis of CaaX prenyltransferases complexed with substrates defines rules of protein substrate selectivity. J. Mol. Biol. 343:417-433.
5. Moores SL, Schaber MD, Mosser SD, Rands E, O'Hara MB, Garsky VM, Marshall MS, Pompliano DL, Gibbs JB. 1991. Sequence dependence of protein isoprenylation. J. Biol. Chem. 266:14603-14610.
6. Finegold AA, Johnson DI, Farnsworth CC, Gelb MH, Judd SR, Glomset JA, Tamanoi F. 1991. Protein geranylgeranyltransferase of Saccharomyces cerevisiae is specific for Cys-Xaa-Xaa-Leu motif proteins and requires the CDC43 gene product but not the DPR1 gene product. Proc. Natl. Acad. Sci. U. S. A. 88:4448-4452.
7. Boyartchuk VL, Ashby MN, Rine J. 1997. Modulation of Ras and a-factor function by carboxyl-terminal proteolysis. Science 275:1796-1800.
8. Ashby MN, King DS, Rine J. 1992. Endoproteolytic processing of a farnesylated peptide in vitro. Proc. Natl. Acad. Sci. U. S. A. 89:4613-4617.
9. Hrycyna CA, Clarke S. 1992. Maturation of isoprenylated proteins in Saccharomyces cerevisiae. Multiple activities catalyze the cleavage of the three carboxyl-terminal amino acids from farnesylated substrates in vitro. J. Biol. Chem. 267:10457-10464.
10. Hrycyna CA, Sapperstein SK, Clarke S, Michaelis S. 1991. The Saccharomyces cerevisiae Ste14 gene encodes a methyltransferase that mediates C-terminal methylation of a-factor and Ras proteins. EMBO J. 10:1699-1709.
11. Ashby MN, Errada PR, Boyartchuk VL, Rine J. 1993. Isolation and DNA sequence of the STE14 gene encoding farnesyl cysteine: carboxyl methyltransferase. Yeast 9:907-913.
12. No JH, de Macedo Dossin F, Zhang Y, Liu YL, Zhu W, Feng X, Yoo JA, Lee E, Wang K, Hui R, Freitas-Junior LH, Oldfield E. 2012. Lipophilic analogs of zoledronate and risedronate inhibit Plasmodium geranylgeranyl diphosphate synthase (GGPPS) and exhibit potent antimalarial activity. Proc. Natl. Acad. Sci. U. S. A. 109:4058-4063.
13. Eastman RT, Buckner FS, Yokoyama K, Gelb MH, Van Voorhis WC. 2006. Thematic review series: lipid posttranslational modifications. Fighting parasitic disease by blocking protein farnesylation. J. Lipid Res. 47: 233-240.
14. Chakrabarti D, Da Silva T, Barger J, Paquette S, Patel H, Patterson S, Allen CM. 2002. Protein farnesyltransferase and protein prenylation in Plasmodium falciparum. J. Biol. Chem. 277:42066-42073.
15. Song JL, White TC. 2003. RAM2: an essential gene in the prenylation pathway of Candida albicans. Microbiology 149:249-259.
16. Piispanen AE, Bonnefoi O, Carden S, Deveau A, Bassilana M, Hogan DA. 2011. Roles of Ras1 membrane localization during Candida albicans hyphal growth and farnesol response. Eukaryot. Cell 10:1473-1484.
17. Park BJ, Wannemuehler KA, Marston BJ, Govender N, Pappas PG, Chiller TM. 2009. Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS. AIDS 23:525-530.
18. Vallim MA, Fernandes L, Alspaugh JA. 2004. The RAM1 gene encoding a protein-farnesyltransferase beta-subunit homologue is essential in Cryptococcus neoformans. Microbiology 150:1925-1935.
19. Nichols CB, Ferreyra J, Ballou ER, Alspaugh JA. 2009. Subcellular localization directs signaling specificity of the Cryptococcus neoformans Ras1 protein. Eukaryot. Cell 8:181-189.
20. Ohya Y, Qadota H, Anraku Y, Pringle JR, Botstein D. 1993. Suppression of yeast geranylgeranyl transferase I defect by alternative prenylation of two target GTPases, Rho1p and Cdc42p. Mol. Biol. Cell 4:1017-1025.
21. Ballou ER, Nichols CB, Miglia KJ, Kozubowski L, Alspaugh JA. 2010. Two CDC42 paralogues modulate Cryptococcus neoformans thermotolerance and morphogenesis under host physiological conditions. Mol. Microbiol. 75:763-780.
22. Ballou ER, Selvig K, Narloch JL, Nichols CB, Andrew Alspaugh J. 2013. Two Rac paralogs regulate polarized growth in the human fungal pathogen Cryptococcus neoformans. Fungal Genet. Biol. 57:58-75.
23. Vallim MA, Nichols CB, Fernandes L, Cramer KL, Alspaugh JA. 2005. A Rac homolog functions downstream of Ras1 to control hyphal differentiation and high-temperature growth in the pathogenic fungus Cryptococcus neoformans. Eukaryot. Cell 4:1066-1078.
24. Shen G, Zhou E, Alspaugh JA, Wang P. 2012. Wsp1 is downstream of Cin1 and regulates vesicle transport and actin cytoskeleton as an effector of Cdc42 and Rac1 in Cryptococcus neoformans. Eukaryot. Cell 11:471-481.
25. Lam WC, Gerik KJ, Lodge JK. 2013. Role of Cryptococcus neoformans Rho1 GTPases in the PKC1 signaling pathway in response to thermal stress. Eukaryot. Cell 12:118-131.
26. Sherman F. 1991. Getting started with yeast. Methods Enzymol. 194:3-21.
27. Murashige T, Skoog F. 1962. A revised medium for rapid growth and bio assays with tobacco tissue cultures. Physiol. Plant. 15:473-497.
28. McDade HC, Cox GM. 2001. A new dominant selectable marker for use in Cryptococcus neoformans. Med. Mycol. 39:151-154.
29. Fraser JA, Subaran RL, Nichols CB, Heitman J. 2003. Recapitulation of the sexual cycle of the primary fungal pathogen Cryptococcus neoformans var. gattii: implications for an outbreak on Vancouver Island, Canada. Eukaryot. Cell 2:1036-1045.
30. Toffaletti DL, Rude TH, Johnston SA, Durack DT, Perfect JR. 1993. Gene transfer in Cryptococcus neoformans by use of biolistic delivery of DNA. J. Bacteriol. 175:1405-1411.
31. O'Meara TR, Norton D, Price MS, Hay C, Clements MF, Nichols CB, Alspaugh JA. 2010. Interaction of Cryptococcus neoformans Rim101 and protein kinase A regulates capsule. PLoS Pathog. 6:e1000776. doi:10.1371 /journal.ppat.1000776.
32. Wormley FL, Jr, Perfect JR. 2005. Immunology of infection caused by Cryptococcus neoformans. Methods Mol. Med. 118:193-198.
33. Casadevall A, Cleare W, Feldmesser M, Glatman-Freedman A, Goldman DL, Kozel TR, Lendvai N, Mukherjee J, Pirofski L-a, Rivera J, Rosas AL, Scharff MD, Valadon P, Westin K, Zhong Z. 1998. Characterization of a murine monoclonal antibody to Cryptococcus neoformans polysaccharide that is a candidate for human therapeutic studies. Antimicrob. Agents Chemother. 42:1437-1446.
34. Mukherjee S, Lee S, Mukherjee J, Scharff MD, Casadevall A. 1994. Monoclonal antibodies to Cryptococcus neoformans capsular polysaccharide modify the course of intravenous infection in mice. Infect. Immun. 62:1079-1088.
35. Cox GM, Mukherjee J, Cole GT, Casadevall A, Perfect JR. 2000. Urease as a virulence factor in experimental cryptococcosis. Infect. Immun. 68: 443-448.
36. Adams AE, Johnson DI, Longnecker RM, Sloat BF, Pringle JR. 1990. CDC42 and CDC43, two additional genes involved in budding and the establishment of cell polarity in the yeast Saccharomyces cerevisiae. J. Cell Biol. 111:131-142.
37. Arellano M, Coll PM, Yang W, Duran A, Tamanoi F, Perez P. 1998. Characterization of the geranylgeranyl transferase type I from Schizosaccharomyces pombe. Mol. Microbiol. 29:1357-1367.
38. Diaz M, Sanchez Y, Bennett T, Sun CR, Godoy C, Tamanoi F, Duran A, Perez P. 1993. The Schizosaccharomyces pombe cwg2 gene codes for the beta subunit of a geranylgeranyltransferase type I required for betaglucan synthesis. EMBO J. 12:5245-5254.
39. Kelly R, Card D, Register E, Mazur P, Kelly T, Tanaka K-I, Onishi J, Williamson JM, Fan H, Satoh T, Kurtz M. 2000. Geranylgeranyltransferase I of Candida albicans: null mutants or enzyme inhibitors produce unexpected phenotypes. J. Bacteriol. 182:704-713.
40. Nichols CB, Perfect ZH, Alspaugh JA. 2007. A Ras1-Cdc24 signal transduction pathway mediates thermotolerance in the fungal pathogen Cryptococcus neoformans. Mol. Microbiol. 63:1118-1130.
41. Alspaugh JA, Cavallo LM, Perfect JR, Heitman J. 2000. RAS1 regulates filamentation, mating and growth at high temperature of Cryptococcus neoformans. Mol. Microbiol. 36:352-365.
42. Waugh MS, Nichols CB, DeCesare CM, Cox GM, Heitman J, Alspaugh JA. 2002. Ras1 and Ras2 contribute shared and unique roles in physiology and virulence of Cryptococcus neoformans. Microbiology 148:191-201.
43. Johnston SA, May RC. 2013. Cryptococcus interactions with macrophages: evasion and manipulation of the phagosome by a fungal pathogen. Cell Microbiol. 15:403-411.
44. Lane KT, Beese LS. 2006. Thematic review series: lipid posttranslational modifications. Structural biology of protein farnesyltransferase and geranylgeranyltransferase type I. J. Lipid Res. 47:681-699.
45. Hast MA, Nichols CB, Armstrong SM, Kelly SM, Hellinga HW, Alspaugh JA, Beese LS. 2011. Structures of Cryptococcus neoformans protein farnesyltransferase reveal strategies for developing inhibitors that target fungal pathogens. J. Biol. Chem. 286:35149-35162.
46. Ohya Y, Goebl M, Goodman LE, Petersen-Bjørn S, Friesen JD, Tamanoi F, Anraku Y. 1991. Yeast CAL1 is a structural and functional homologue to the DPR1 (RAM) gene involved in ras processing. J. Biol. Chem. 266:12356-12360.
47. Roberts PJ, Mitin N, Keller PJ, Chenette EJ, Madigan JP, Currin RO, Cox AD, Wilson O, Kirschmeier P, Der CJ. 2008. Rho family GTPase modification and dependence on CAAX motif-signaled posttranslational modification. J. Biol. Chem. 283:25150-25163.
48. Price MS, Nichols CB, Alspaugh JA. 2008. The Cryptococcus neoformans Rho-GDP dissociation inhibitor mediates intracellular survival and virulence. Infect. Immun. 76:5729-5737.
49. ras to the plasma membrane. Cell 63:133-139.
50. Hancock JF, Cadwallader K, Paterson H, Marshall CJ. 1991. A CAAX or a CAAL motif and a second signal are sufficient for plasma membrane targeting of ras proteins. EMBO J. 10:4033-4039.
51. Banks IR, Specht CA, Donlin MJ, Gerik KJ, Levitz SM, Lodge JK. 2005. A chitin synthase and its regulator protein are critical for chitosan production and growth of the fungal pathogen Cryptococcus neoformans. Eukaryot. Cell 4:1902-1912.
52. Schafer WR, Rine J. 1992. Protein prenylation: genes, enzymes, targets, and functions. Annu. Rev. Genet. 26:209-237.
53. Perfect JR, Lang SD, Durack DT. 1980. Chronic cryptococcal meningitis: a new experimental model in rabbits. Am. J. Pathol. 101:177-194.
54. Nielsen K, Cox GM, Wang P, Toffaletti DL, Perfect JR, Heitman J. 2003. Sexual cycle of Cryptococcus neoformans var. grubii and virulence of congenic a and isolates. Infect. Immun. 71:4831-4841.